ERIC DOBMEIER - 29 Apr 2025 Form 4 Insider Report for Jade Biosciences, Inc. (JBIO)

Role
Director
Signature
/s/ Elizabeth Balta, as attorney-in-fact for Eric Dobmeier
Issuer symbol
JBIO
Transactions as of
29 Apr 2025
Transactions value $
$0
Form type
4
Filing time
01 May 2025, 18:00:21 UTC
Previous filing
01 May 2025
Next filing
13 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JBIO Stock Option (Right to Buy) Award $0 +23K $0.00 23K 29 Apr 2025 Common Stock 23K $10.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer.